RE: Tsx13 May 2021 18:41
Inorganic growth opportunities: With the two acquisitions successfully bedded-in, i3 is now actively scoping fresh opportunities for growth alongside its organic growth strategy in the Clearwater play. We estimate that the company started the year with around US$8.5m of cash, and forecast a further c.US$9m of FY21 free cash flow (net of dividends) which can be used for acquisitions. With net debt/EBITDA at a forecasted 1.1x (FYE21), there is also the potential to use debt finance for new transactions, providing options other than just new equity to finance larger deals. Any transaction priced below 5x EBITDA will be incrementally accretive to cash flow and dividend yield per share (assuming like-for-like funding structure), illustrating the growth potential through M&A.
We initiate coverage on i3 with a DCF-derived (2P NAV, NPV10) target price of 16p/shr. Note that this does not include any value for the Serenity discovery in the North Sea, worth an additional 5p/shr risked on our numbers. Our target price currently offers some 93% upside, with additional upgrades likely in the event of success with the ongoing farm out process on Serenity, and further M&A activity in Canada. Accordingly, we carry a BUY recommendation.